FDA expands use of Novartis vaccine; New hep C model opens door for vaccine;

> FDA has approved the use of Novartis' ($NVS) quadrivalent meningococcal vaccine in infants as young as 2 months old. Release

> A new hepatitis C model could help develop a vaccine to tackle the virus. Item

> A New York Times op-ed has highlighted how vaccines have helped apes. Op-ed

> NIH has awarded TechnoVax $600,000 towards development of a universal influenza vaccine. News

> Emergent BioSolutions has won approval to market its anthrax vaccine in Germany. Article

> Officials from 17 countries have met in Dakar to discuss sustainable immunization financing programs. Piece

> Immunovaccine has obtained a $5 million loan to support clinical trials of its cancer vaccines. Item

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

With COVID vaccinations expected to start in the coming weeks, 2021 is shaping up to be quite a year for the companies with leading vaccines.

The U.K. became the first Western country to authorize a COVID-19 vaccine, making the Pfizer/BioNTech shot the first mRNA vaccine for widespread use.